Giant cell lesions in noonan syndrome: Case report and review of the literature

Head and Neck Pathology

Volumn 4, Issue 2, 2010, Pages 174-177

  Bufalino, Andreia ^a   Carrera, Manoela ^a   Carlos, Roman ^b   Coletta, Ricardo D ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Centro Clinico de Cabeza y Cuello   (Guatemala)

Author keywords

Clinical features; Giant cell lesion; Noonan syndrome; Noonan like multiple giant cell lesion syndrome; PTPN11 mutation

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2; PTPN11 PROTEIN, HUMAN;

ARTICLE; CASE REPORT; CHILD; GENETICS; GIANT CELL; HUMAN; MALE; MANDIBLE; MUTATION; NOONAN SYNDROME; PATHOLOGY;

CHILD; GERM-LINE MUTATION; GIANT CELLS; HUMANS; MALE; MANDIBLE; NOONAN SYNDROME; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11;

EID: 77953083095     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-010-0178-2     Document Type: Article

References (17)

1. Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet. 1985; 21: 493-506.
2. Noordam K. Expanding the genetic spectrum of Noonan syndrome. Horm Res. 2007; 68(Suppl 5): 24-7.
3. Cohen MM Jr, Gorlin RJ. Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet. 1991; 40: 159-66.
4. Hanna N, Parfait B, Talaat IM, Vidaud M, Elsedfy HH. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome. Clin Genet. 2009; 75: 568-71.
5. Lee JS, Tartaglia M, Gelb BD, et al. Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome. J Med Genet. 2005; 42: e11.
6. Imai Y, Kanno K, Moriya T, et al. A missense mutation in the SH3BP2 gene on chromosome 4p16. 3 found in a case of nonfamilial cherubism. Cleft Palate Craniofac J. 2003; 40: 632-8.
7. Kosaki K, Suzuki T, Muroya K, et al. PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. J Clin Endocrinol Metab. 2002; 87: 3529-33.
8. Wolvius EB, de Lange J, Smeets EE, van der Wal KG, van den Akker HP. Noonan-like/multiple giant cell lesion syndrome: report of a case and review of the literature. J Oral Maxillofac Surg. 2006; 64: 1289-92.
9. Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2005; 6: 45-68.
10. van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet. 1994; 53: 187-91.
11. Jongmans M, Sistermans EA, Rikken A, et al. Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. Am J Med Genet A. 2005; 134A: 165-70.
12. Jorge AA, Malaquias AC, Arnhold IJ, Mendonca BB. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway. Horm Res. 2009; 71: 185-93.
13. DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008; 132: 1251-62.
14. Moe SM, Drueke T, Lameire N, Eknoyan G. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007; 14: 3-12.
15. Edwards PC, Fantasia JE, Saini T, Rosenberg TJ, Sachs SA, Ruggiero S. Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102: 765-72.
16. Ernst LM, Quinn PD, Alawi F. Novel oral findings in Schimmelpenning syndrome. Am J Med Genet A. 2007; 143A: 881-3.
17. Jafarov T, Ferimazova N, Reichenberger E. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism. Clin Genet. 2005; 68: 190-1.